Rezolute, Inc. (RZLT)
3.11
-0.02
(-0.64%)
USD |
NASDAQ |
Apr 02, 16:00
3.08
-0.03
(-0.96%)
After-Hours: 19:47
Rezolute Research and Development Expense (TTM) : 63.64M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| XOMA Royalty Corp. | 1.712M |
| ADMA Biologics, Inc. | 4.761M |
| Silvergate Capital Corp. | -- |
| ACADIA Pharmaceuticals, Inc. | 328.80M |